Catecholamine effects on human melanoma cells evoked by α1-adrenoceptors

Archives of Dermatological Research

Volumn 296, Issue 3, 2004, Pages 112-119

  Scarparo, Ana Cristina ^a   Sumida, Dóris Hissako ^b   Patrão, Marília T C C ^c   Avellar, Maria Christina W ^c   Visconti, Maria Aparecida ^a   Castrucci, Ana Maria De Lauro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

1 Adrenoceptors; Catecholamines; Cell proliferation; SK Mel 23 melanoma cells; Tyrosinase activity

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ASCORBIC ACID; BENOXATHIAN; CATECHOLAMINE; DACTINOMYCIN; MONOPHENOL MONOOXYGENASE; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN;

ADRENERGIC SYSTEM; ARTICLE; CATECHOLAMINE METABOLISM; CELL PROLIFERATION; CELL STRAIN SK MEL 23; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA CELL; PIGMENT CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADRENERGIC ALPHA-AGONISTS; BINDING, COMPETITIVE; CELL DIVISION; CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; NOREPINEPHRINE; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-1; SKIN NEOPLASMS;

EID: 4344634280     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-004-0488-x     Document Type: Article

References (72)

1. 1B-adrenergic receptor through a p42MAPKinase/ p21Cip1/ WAF1-dependent pathway. FEBS Lett 436:131-138
2. 1- Adrenoceptors in testosterone-induced prostatic hypertrophy. Eur J Pharmacol 341:119-126
3. Boissy RE (1988) The melanocyte: its structure, function and subpopulations in skin, eyes and hair. Dermatol Clin 6:161-174
4. 2-adrenergic receptors. FASEB J 6:832-839
5. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) IV international union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136
6. 1A-adrenoceptors. Biochem J 343:231-239
7. Cucchi ML, Frattini P, Santagostino G, Orecchia G (2000) Higher plasma catecholamine and metabolite levels in the early phase of nonsegmental vitiligo. Pigment Cell Res 13:28-32
8. 1L- adrenoceptor pharmacology in functional studies. Eur J Pharmacol 370:337-343
9. DeOliveira AR, Castrucci AML, Visconti MA (1996) Cellular signalling in vertebrate pigment cells. Braz J Med Biol Res 29:1743-1749
10. 1B-adrenoceptor subtype. Am J Obstet Gynecol 189:1472-1480
11. 1D-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Mol Pharmacol 47:977-985
12. Filadelfi AMC, Rodrigues PR, Castrucci AML, Visconti MA (2002) Adrenoceptors in avian and fish pigment cells. J Comp Physiol B 172:599-606
13. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (1987) Dermatology in general medicine, 3rd edn. McGraw-Hill, New York
14. Fujii R (2000) The regulation of motile activity in fish chromatophores. Pigment Cell Res 13:300-319
15. Fujii R, Oshima N (1994) Factors influencing motile activities of fish chromatophores. In: Advances in comparative and environmental physiology. Springer, Berlin Heildelberg New York, pp 1-54
16. Fuller BB, Drake MA, Spaulding DT, Chaudhry F (2000) Downregulation of tyrosinase activity in human melanocyte cell cultures by yohimbine. J Invest Dermatol 114:268-276
17. 1-Adrenoceptors: function and phosphorylation. Eur J Pharmacol 389:1-12
18. Gazith J, Cavey MT, Cavey D, Shroot B, Reichert U (1983) Characterization of the β-adrenergic receptors of cultured human epidermal keratinocytes. Biochem Pharmacol 32:3397-3403
19. 2+ in smooth muscle. Nature 329:333-335
20. 1-Adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells. Role in mitogenesis. J Biol Chem 271:8977-8982
21. Hugh D, Grennan A, Abugila MA, Weinkove C (1987) Ascorbic acid as an antioxidant in measurements of catecholamines in plasma. Clin Chem 33:569-571
22. Iozumi K, Hoganson GE, Pennella R, Everett MA, Fuller BB (1993) Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes. J Invest Dermatol 100:806-811
23. 1- Adrenoceptor subtypes differentially couple to growth promotion and inhibition in Chinese hamster ovary cells. Biochem Biophys Res Commun 272:906-911
24. 2+ increase in human epidermal keratinocytes. J Invest Dermatol 96:234-237
25. Koizumi H, Tanaka H, Ohkawara A (1997) β-Adrenergic stimulation induces activation of protein kinase C and inositol 1,4,5-triphosphate increase in epidermis. Exp Dermatol 6:128-132
26. Kötter K, Klein J (1999) Adrenergic modulation of astroglial phospholipase D activity and cell proliferation. Brain Res 830:138-145
27. Laskin JD, Lee E, Yurkow EJ, Laskin DL, Gallo MA (1985) A possible mechanism for psoralen phototoxicity not involving direct interaction with DNA. Proc Natl Acad Sci USA 82:6158-6162
28. Lefkowitz RJ (1998) G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem 273:18677-18680
29. Le Poole IC, van den Wijngaard RMJGJ, Smit NPM, Oosting J, Westerhof W, Pavel S (1994) Catechol-O-methyltransferase in vitiligo. Arch Dermatol Res 286:81-86
30. 1 adrenergic receptors. J Biol Chem 273:30033-30038
31. Lomasney JW, Alien LF, Lefkowitz RJ (1995) Cloning and regulation of catecholamine receptor genes. In: Weintraub BD (ed) Molecular endocrinology: basic concepts and clinical correlations. Raven Press, New York, pp 115-131
32. Maxwell LC, Herlihy JT, Riedel JL (1983) Effects of ascorbic acid and EDTA on vascular concentration-response to catecholamines. Microvasc Res 26:81-88
33. Mengeaud V, Ortonne JP (1994) Regulation of melanogenesis induced by 5-methoxypsoralen without UV light in murine melanoma cells. Pigment Cell Res 7:245-254
34. 2+. Pharmacol Rev 40:87-119
35. Morrone A, Picardo M, de Luca C, Terminali O, Passi S, Ippolito F (1992) Catecholamines in vitiligo. Pigment Cell Res 5:65-69
36. Naeyaert JM, Eller M, Gordon PR, Park H-Y, Gilchrest BA (1991) Pigment content of cultured human melanocytes does not correlate with tyrosinase level. Br J Dermatol 125:297-303
37. 1-adrenoceptor subtype mRNAs in human proximal urethra. Br J Pharmacol 123:1289-1293
38. Neal MJ, Cunningham JR, Mattheus KL (1999) Release of endogenous ascorbic acid preserves extracellular dopamine in the mammalian retina. Invest Ophthalmol Vis Sci 40:2983-2987
39. 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br J Pharmacol 121:665-670
40. Nordlund JJ, Abdel-Malek ZA, Boissy RE, Rheins LA (1989) Pigment cell biology: an historical review. J Invest Dermatol 92:535-605
41. Picardo M, Passi S, Morrone A, Grandinetti M, Di Carlo A, Ippolito F (1994) Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 7:110-115
42. Pomerantz SH (1966) The tyrosine hydroxilase activity of mammalian tyrosinase. J Biol Chem 241:161-168
43. 1-Adrenoceptor subtypes in rat epididymis and the effects of sexual maturation. Biol Reprod 66:508-515
44. Quevedo WC Jr, Fitzpatrick TB, Szabo G, Jimbow K (1987) Biology of melanocytes. In: Fitzpatrick TB, Eisen AZ, Wolf K, Freedberg IM, Austen KF (eds) Dermatology in general medicine, 3rd edn. McGraw-Hill, New York, pp 224-251
45. 1D. Biochem Biophys Res Commun 200:1177-1184
46. 1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. J Biol Chem 271:5839-5843
47. 1A-Adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of phospholipase in Rat-1 fibroblasts: inhibition by protein kinase A. J Pharmacol Exp Ther 284:576-585
48. Scarparo AC, Visconti MA, Oliveira AR, Castrucci AML (2000) Adrenoceptors in normal and malignant human melanocytes. Arch Dermatol Res 292:265-267
49. Schallreuter KU, Wood JM, Lemke R, LePoole C, Das P, Westerhof W, Pittelkow MR, Thody AJ (1992a) Production of catecholamines in the human epidermis. Biochem Biophys Res Commun 189:72-78
50. Schallreuter KU, Wood JM, Ehrke C, Lemke R (1992b) Calcium transport and regulation in human primary and metastatic melanoma. Biochem Biophys Acta 1160:127-133
51. Schallreuter KU, Wood JM, Pittelkow MR, Swanson NN, Steinkrauss V (1993) Increased in vitro expression of β2-adrenoceptors in differentiating lesional keratinocytes of vitiligo patients. Arch Dermatol Res 285:216-220
52. Schallreuter KU, Wood JM, Ziegler I, Lemke R, Pittelkow MR, Lindsey NJ, Gutlich M (1994) Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim Biophys Acta 1226:181-192
53. Schallreuter KU, Wood JM, Pittelkow MR, Büttner G, Swanson NN, Koerner C, Ehrke C (1995) Increased monoamine oxidase A activity in the epidermis of patients with vitiligo. Arch Dermatol Res 288:14-18
54. 1-adrenoceptor signal transduction system on human melanocytes. Exp Dermatol 5:20-23
55. 1A-subtipe. Eur Urol 36:7-10
56. Sheerbrooke WC, Hadley ME, Castrucci AML (1988) Melanotropic peptides and receptors: an evolutionary perspective in vertebrates. In: Hadley ME (ed) The melanotropic peptides, vol III. CRC Press, Washington, pp 175-189
57. Silva MA, Megale A, Avellar MCW, Porto CS (1999) Expression and pharmacological characterization of ar adrenoceptors in rat seminal vesicle. Eur J Pharmacol 381:141-149
58. Spector MS, Auer KL, Jarvis WD, Ishac EJ, Gao B, Kunos G, Dent H (1997) Differential regulation of the mitogen-activated protein and stress-activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes. Mol Cell Biol 17:3556-3565
59. 2-adrenoceptors of cultured melanoma cells. Br J Dermatol 123:163-170
60. Steinkrauss V, Steinfath M, Körner C, Mensing H (1992) Binding of β-adrenergic receptors in human skin. J Invest Dermatol 98:475-80
61. 1A adrenoceptor in rabbit. Br J Pharmacol 129:1569-1576
62. Szmigielski A, Szmigielska H, Zalewska-Kaszubska J, Marczak G (1997) The cooperation between the influx of extracellular calcium and aradrenoceptor- induced translocation of protein kinase C. Pharmacol Res 36:211-219
63. Tsuji M, Kuno T, Tanaka C, Ichihashi M, Mishima Y (1983) β-Adrenergic receptors of B16 melanoma cell. Arch Dermatol Res 275:415-416
64. 2- and β-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J Biol Chem 273:24624-24632
65. 1C-adrenergic receptors. J Biol Chem 270:17196-17203
66. 1D- Adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol Pharmacol 51:764-775
67. 2 and mitogen-activated protein kinase by aradrenergic receptors in Madin-Darby canine kidney cells. J Clin Invest 97:1302-1310
68. q-induced inhibition of cell proliferation. Biochem Biophys Res Commun 281:1019-1023
69. Yu SS, Lefkowitz RJ, Hausdorff WP (1993) β-Adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J Biol Chem 268:337-341
70. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, Glembotski CC (1997) A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol 139:115-127
71. Zhao H, Li L, Boissy RE, Nordlund JJ (1996) Effects of autonomic neurotransmitters on human epidermal and ocular melanocytes in culture. In: XVIth International Pigment Cell Conference (Abstract), p 85
72. 1,-Adrenoceptor subtypes. Eur J Pharmacol 375:261-276